Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

LYNPARZA Receives Additional and Broad Approval in the U.S. for Ovarian Cancer

americanpharmaceuticalreviewAugust 21, 2017

Tag: Lynparza , PARP , ovarian cancer

PharmaSources Customer Service